Medica Special Autumn 2011

Wales

W A L E S

M E D I C A

S P E C I A L

2 0 1 1

open for business

M E D I WA L E S I S S U P P O R T E D B Y T H E W E L S H G O V E R N M E N T

WALES medica special

Your sterile single-use solution, without compromise

Our combination of high quality innovative products and exceptional levels of service provide supreme clinical value.

Specialities served: General eneral and VVascular, ascular ENT/MaxFax, Gynaecological, Neurosurgical rosurgical

T: +44 (0)1792 797910 7910 F: +44 (0)1792 797955 E: info@dtrmedical.com nfo@dtrmedical.com

www.dtrmedical.com

COME AN D V I SI T U S AT M EDICA S TAN D 16 F 30

Medica 16 - 19 November 2011 – Messe Düsseldorf, Germany

The Welsh Pavilion: Hall 16 Stand F30 This MediWales “Medica Special” Review is your introduction to the thriving medical technology sector in Wales. It includes editorial from both MediWales and the Welsh Government, with a directory of all companies on the Welsh Government mission 2011.

Several companies are represented further through case studies, providing a snapshot of some of the most exciting products and services being offered by Welsh companies in this sector.

Medica is the world’s largest and leading global exhibition for the medical sector, and has been established for over 40 years. It runs alongside the leading international fair for medical manufacturing supplies, Compamed.

Together, Medica and Compamed occupy all 19 halls of the Düsseldorf Exhibition Centre and organisers expect more than 600 exhibitors from over 60 countries.

Medica covers the entire range of out-patient and in-patient healthcare, including: electrical medicine, medical devices, laboratory technology, diagnostics, physiotherapy, orthopaedic technology, medical supplies, (essential supplies and consumables)information and communication technology, textiles, medical furniture, furnishings, facility management, and building services.

At the same time, Compamed addresses all aspects of supplies to the medical manufacturing sector: raw materials, components, parts, packaging, and services for use in medical device production.

The Welsh Government is a democratically elected body, which was established in May 1999. It has devolved powers and is responsible for developing and implementing policies in Wales on a broad range of economic issues, including economic development, education, the environment, agriculture, housing, roads and transport.

This year’s Welsh delegates are supported by the Welsh Government to attend Medica. In spite of the economic situation, both MediWales and Welsh Government are confident this mission will benefit the delegates, ensuring networking opportunities to place Welsh life science companies firmly in the global spotlight once again.

MediWales has been active for over 19 years and is the representative body for the life science sector in Wales.

Supported by the Welsh Government, MediWales is owned by its members and led by directors drawn from senior industrialists and academics in Wales. MediWales generates a unique environment for networking, collaboration and communications between industry, academia and health service members. This is delivered through an active schedule of events and publications supported by the MediWales website and maintained via constant communication with stakeholders. From this pivotal role, MediWales is able to represent both its members and the wider sector to governmental and international partners.

MediWales is a founder member of Medilink UK, a national

Contents Features Wales: Open for Business 4-5 Life Sciences at the heart of Welsh Government 6-7 Wales Pavilion Directory

9-15

Company Case Studies Alere Connected Health CellPath Chromogenex Direct Healthcare Services DTR Medical GX Group Pulse Medical Technologies

16 17 18 19 20 21 22

Forum Manager: gwyn.tudor@mediwales.com Project Manager: debbie.laubach@mediwales.com Comms Manager: jess.fisher@mediwales.com Project Coordinator: ruth.campbell@mediwales.com Web: www.mediwales.com Telephone: +44 (0)29 2047 3456 7 Schooner Way, Atlantic Wharf, Cardiff CF10 4DZ

health technology business support organisation that represents

MediWales Chairman: Mr Greg Baily, Huntleigh

the interests of around 3000 organisations across the UK.

The MediWales Medica Special is designed by Teamworks Design and Marketing

WALES medica special

4

Wales: open for business MediWales – the Welsh life science forum - works closely with Welsh Government departments for business and health, the NHS, academics and industry to ensure operations and policy in the Welsh life science sector reflect joined up, multidisciplinary thinking. By Jess Fisher, MediWales A devolved nation of approximately three million people, with an independent NHS and a thriving life science industry, Wales is aware of the opportunities being small offers.

Frequently facilitated by MediWales, senior decision makers in academia, business and the NHS regularly meet to discuss how to better Welsh healthcare and the economy. The focus of discussions this year has progressed from realising better communications to realising tangible outputs.

The resounding message is that Wales is open for business: with sub sector strengths in wound healing, diagnostics, assistive technology and clinical trials, this is the place to carry out your research and development (R&D). Since the Welsh Government restructured in summer 2010, 70% of all grants awarded have been to life science companies: companies understand that Wales not only offers a cost effective manufacturing base but houses the necessary skills, expertise and infrastructure to provide an excellent environment for research.

Feedback from Advamed – the largest American health technology trade association – on the perception of Europe as a destination for R&D holds potential consequences for Wales.

American companies’ experience infers that health technology trials and evaluations in Europe can be done

at half the time and cost, compared to in America. The design and patient recruitment for studies is viewed as simpler, with a free healthcare system naturally encouraging greater patient engagement.

This knowledge provides Wales with an opportunity to attract clinical trials/ evaluations and commercialisation of medical technologies from outside Europe due to its unique size, networks and its devolved NHS.

Penn Pharma Penn is a leading provider of integrated pharmaceutical development, clinical trial supply and custom manufacturing services to the international healthcare industry. Offering specialised contract manufacture and Qualified Person release services, Penn are an excellent contract research organisation supplier. Penn manufactures to GMP (Good Manufacturing Practice) and is licensed by the UK’s MHRA (Medicines and Healthcare products Regulatory Agency) and is FDA (US Food and Drug Administration) inspected.

Cedar

The following section takes a brief look at just a few of the organisations that make Wales such an attractive location to carry out R&D: Cardiff University: Welsh Anaesthetic Institute (WAI) Working closely with medical devices manufacturers, the team of senior academics and consultant anaesthetists have an extensive portfolio including: developing patents; evaluating medical equipment using laboratory-based tests; user assessments and clinical trials; and expert consultancy. The international reputation and expertise of Dr Antony Wilkes, Research Director and CEN Consultant, cannot be underestimated.

They boast a state of the art Clinical Research Facility with excellent collaborative support from NHS Research and Development. Open for business, the institute welcomes contact from those wishing to initiate studies.

Cedar is an NHS evaluation centre, providing information and recommendations on emerging health technologies, medical devices, diagnostic testing, healthcare interventions and NHS service configuration.

Cedar has a successful history of evaluation for a succession of UK government funded NHS organisations.

Cedar is part of the Cardiff and Vale University Health Board (UHB) and has recently won a major 3-year contract with the National Institute for Health and Clinical Excellence (NICE) working on their Evaluation Pathway for Medical Technologies.

In addition to their work for NICE, Cedar is able to undertake bespoke work for organisations. Recent examples include work for the Medicines and Healthcare Products Regulatory Agency (MHRA), Department of Obstetrics and Gynaecology at Cardiff and Vale UHB and the medical device industry.

5

SMTL The Surgical Materials Testing Laboratory, part of the Welsh NHS, provides a range of testing and technical services to the NHS and the medical device industry worldwide, including: • Physical and Biological testing of disposable medical devices to National and International standards • Dressings testing and bandage testing • Biological and microbiological testing • Hosiery and glove testing • Environmental monitoring of cleanrooms (to ISO 14644-1 and GMP) • Surgical instrument evaluations (single use and reusable) • Test method development, R&D and incident investigation Cardiff University – Wound Healing Research Unit (WHRU) WHRU has three core activities: specialist clinical services, research, and education and training.

Research includes conducting clinical trials; biological research (with a particular emphasis on microbiology and material science); physical measurement (the interface of medicine and engineering/electronics); and health services research (including health economics). The target markets include health professionals working with non-healing acute or chronic wounds and health care companies involved in specialist wound care.

HIRU The Health Information Research Unit (HIRU) based at Swansea University established the Secure Anonymised Information Linkage (SAIL) project to link together the widest possible range of anonymised person-based data using the School of Medicine’s IBM supercomputer (Blue C).

Having successfully accomplished this, HIRU is expanding the databank, both in types of dataset and in geographical coverage, providing a valuable resource for health-related research and service development, whilst complying with the requirements of data protection legislation and confidentiality guidelines. eHealth Industries Innovation (ehi2) Centre ehi² provides businesses with opportunities to test, adapt, improve and evaluate ehealth products and services in a safe and reliable environment. It advises and assists companies and can facilitate access to clinicians, academic experts, NHS organisations, and national NHS IT and ICT programmes.

It works with the NHS and other health systems to identify needs for new products and services.

Institute of Life Science Phase 2 of the Institute of Life Science at Swansea University is a £30 million facility providing state-of-the-art clinical research facilities, and an imaging suite. This institute provides an environment to undertake world-class and internationally recognised research, proving an excellent location for highgrowth companies in the sector.

These organisations, and others, are supported and represented through several

working groups created to influence the Welsh Government’s policies and agendas for Welsh healthcare.

MediWales’s contribution is through our clinical access group that has evolved into the more broad Life Science Expert Advisory Group, bringing key representatives from academia, business and clinical settings (ABC) together, with invited guests from Government, to suggest improvements to the healthcare system.

The Welsh Government’s National Institute for Social Care and Health Research (NISCHR) Academic Health Science Collaboration (AHSC) Advisory Task and Finish Group is developing a framework proposal for interaction between the NISCHR AHSC and Industry.

A key part of NISCHR’s strategic work programme is developing an R&D infrastructure to build capacity and support excellence across Wales. The group will develop recommendations for maximising the attractiveness of Wales for partnering opportunities with the private sector, including ways to increase access to clinical trials.

Missions such as Medica are vital to this sector, providing a platform to build Wales’s reputation as a desirable place to do business, innovate and carry out specialist research.

WALES medica special

6

Life Science – at the heart of Welsh Government A priority sector for Welsh Government, the life science industry is diverse, researchdriven and globally focussed, with new Welsh subsectors continuing to develop.

Comprising pharmaceutical, biotechnology and medical technology businesses, Wales houses one of the largest medical device clusters in the UK, with a focus on diagnostics, wound care, e-health and contract research.

This burgeoning Welsh sector has grown by over 19 per cent in the last three years, no doubt partly attributable to its highly skilled workforce.

Many Welsh companies are leading players in their specialist areas, such as: medical technology (Biomet UK, Huntleigh and Gyrus ACMI - an Olympus company); diagnostics (Siemens Healthcare Diagnostics and Ortho Clinical Diagnostics); wound healing (ConvaTec, Biomonde and Frontier Medical Group); and contract research organisations and their supply chain (Aptuit, Biotec Services International and Penn Pharma).

“What’s happening here in Wales is comparable to many biotech hubs around the world, with a concentration of expertise and R&D excellence”, said Dr Stephen Minger, Head of Research and Development for Cell Technologies at GE Healthcare, Cardiff, home to the company’s international centre for groundbreaking work in stem cell technologies.

Complementary to GE’s stem cell centre, Wales is home to BTG - the UK’s biggest biotechnology group. Wales has a strong representation of in-vitro diagnostic companies, including Albany Molecular Research Inc. (AMRI), Quay Pharma and Quotient Bioresearch.

Wales has historically provided an excellent location to do business, with

global companies such as Siemens Healthcare Diagnostics Products Ltd; Ortho Clinical Diagnostics, Biomet and Biomonde, choosing to locate parts of their business here.

Innvovation and Academic Strengths

Calon Cardio – Implantable pumps for treatment of heart failure.

Hall Lock System – Device which prevents healthcare staff from mistakenly injecting drugs and other substances into the wrong part of the body.

In Wales you’ll find specialist organisations with industry-leading facilities, and partners who are taking the science forward with innovative techniques.

Huntleigh Diagnostics – Device which detects the early on-set of lower limb arterial disease.

Recent Innovations:

system.

Microvisk – Devices which monitor

MedaPhor – Ultrasound training

clotting levels for patients on drugs such as Warfarin.

Haemair – Respiratory aids which mimic the performance of healthy lungs.

Invacare – Portable oxygen filling

simulator.

Cal2Cal – Informatics – system to monitor chronic disease and improve preventative care of the elderly.

7

Recent Funds Raised include: CellNovo Microvisk Q-Chip Diurnal Acuitas Medical Calon Cardio

£30m £10.5m £8.5m £1m £700k + £500k

Committing to developing the necessary infrastructure for Wales to do business in this sector, the Welsh Government has invested in projects such as Phase 2 of the Institute of Life Science at Swansea University. This development showcases the partnership between the School of Medicine and the NHS in Wales. This £30 million facility provides additional state-of-the-art clinical research facilities, an imaging suite, also housing the innovative Centre for NanoHealth and the forward-looking Centre for Health Informatics, Research and Evaluation (CHIRAL). This institute creates a fit-for-purpose working environment necessary to undertake world-class and internationally recognised research, proving an excellent location for high-growth companies in the sector.

To help advise Welsh Government on the development and delivery of a live life science strategy for Wales, the Life Science Sector Panel was appointed earlier in 2011. Chaired by well-known biotech

entrepreneur Professor Sir Chris Evans, the team comprises industry experts.

Medical technology is an important subsector and the Life Sciences Team and Panel are committed to support business growth in this area. This is clearly demonstrated in the support given to Welsh businesses to attend Medica this year, with 40 business exhibitors and delegates attending this medical technology trade fair, the largest in the world.

Supporting International Business Success The Welsh Government’s Life Science Team focus on identifying and assisting companies to locate and increase their business in Wales. The team is exploring the business methodologies and supply chains of existing life science companies in Wales in order to create a strategy that will enhance and develop the cluster.

The team can offer advice and support for inward investment, accessing skills and employee development, access to NHS procurement advice, trade and export development, innovation, R&D, and commercialisation. Welsh Government offers financial support to eligible companies developing R&D and innovation in Wales and those significantly growing their business footprint.

Why Wales?

In Wales we know what inward investors need, and the commercial pressures you face – we’ve been helping companies locate here for decades.

People and training - A skilled workforce is among a company’s most important asset. Fortunately in Wales we have two medical schools and our universities supply over 34,000 graduates each year. With a track record of academic-industrial collaboration, our graduates have the skills to join your company. Good quality companies and universities keep graduates in Wales – explaining why our staff retention is higher than the UK average into the potential labour market.

Property - Wales has an exceptional variety of business property – from serviced offices to international headquarters; starter industrial units to R&D incubators - and we even have property with runway access or dedicated airspace.

Access to funding - We encourage business growth by identifying sources of support and funding in areas such as skills development, academic collaboration and business expansion.

To find out more about life science business in Wales, join us at our Medica stand, Hall 16 Stand nr F30, or contact us:

From left to right, Dr Graham Guildford, Professor Sir Chris Evans, Dr Penny Owen, Professor Gareth Morgan, Gwyn Tudor

tel: 03000 6033000 email: business@wales.gsi.gov.uk.

WALES medica special

What MATCH does

About MATCH The Multidisciplinary Assessment of Technology Centre for Healthcare (MATCH) is a well-established research collaboration between four leading UK universities (Birmingham, Brunel, Nottingham & Ulster) and is funded since 2003 by the Engineering and Physical Sciences Research Council and partner contributions.

MATCH helps improve decision-making for technology

Assesses value …

suppliers and procurement agencies. It enables

…by developing methods and models to assess the value of

companies to identify better products earlier in the

products at each stage of development, from identification of

design process and bring them to market sooner, with

need through to mature offerings in the market.

greater confidence that the value to patients and others

Optimises product development and manufacture…

will be consistently defined and readily recognised.

…by researching processes for improving information and

To this end, MATCH delivers: standardised methods for

decision-making, leading to more effective development and

establishing clinical value; new approaches to capturing

production processes, better clinical integration and improved

user needs for early design and in-use upgrades; best of

provision for users.

breed research into production and decision-making

Engages end users…

processes; and a forum for engaging regulators and

…by employing empirically based valuations of health and

finding better ways forward for all concerned.

related benefits to inform value models and develop methods for engaging with users at the conception and design stages.

MATCH advert

Focuses on Industry… …by maintaining a strong industrial perspective, and using real industrial problems to drive and ground its research activities.

How can MATCH help my business?

The MATCH Affiliate Scheme will provide you with access to experts who will support your staff, helping them transform your company's competitive performance by embedding flagship techniques, derived

®

from best-practice in healthcare technology assessment and user needs analysis.

For further information please contact Elizabeth Deadman match@brunel.ac.uk 01895 266050 or check the MATCH website: www.match.ac.uk/sme.php MATCH01

8

Our research.Your business.

The perfect MATCH

9 WA L E S PAV I L I O N D I R E CTO R Y

Welsh Government - Life Science Sector Welsh Government Life Science Sector Tel: +44 (0)3000 6 03000 Email: business@wales.gsi.gov.uk

The Welsh Government is a democratically elected body. It has devolved powers and is responsible for developing and implementing policies in Wales on a broad range of economic issues, including economic development, education, and technology and innovation. Life Science is a priority sector for the region, and a dedicated team is in place to support the growth of the life science sector in Wales

Attending: Cari-Anne Quinn, Senior Business Development Manager Chris Davies, Business Development Manager Tony Sagona, Business Development Manager

Alere Mob: +44 (0)7876 712021 Customer Care Team Tel: +44 (0) 161 483 5884 Fax: +44 (0) 161 483 5778 Email: david.muxworthy@alere.com Skype: muxwo123 Web: www.hometelehealthltd.co.uk and www.alere.co.uk

Alere Connected Health (ACH) formerly Home Telehealth Ltd (now part of the Alere group) is a telehealth and telemedicine organisation specialising in the provision of clinical managed services and telemedicine technologies for remote health and social care monitoring of patients with long-term conditions.

ACH has won three consecutive National Awards in 2008-2010 for “Innovation and Partnering with the NHS”, with over 10 years’ experience in delivering telehealth, telemedicine and technologyenabled care to NHS and Local Authority health and care organisations.

ACH has delivered services to the NHS to over 1,200 long term condition (LTC) patients reducing unplanned emergency admissions by 50%, with a return on investment (ROI) of 112%, thereby allowing patients to remain at home whilst providing support and education to facilitate better self-management.

Objectives at Medica: Identify telemedicine and telehealth technologies that ACH can use on their programmes or distribute in the UK market and also look for European distributors of products they have access to.

Asalus Medical Instruments Limited 8th Floor Eastgate House 35-43 Newport Road Cardiff, UK, CF24 0AB Tel: +44 (0) 292 049 7097 Website: www.asalus.co.uk

Asalus is developing three innovative medical devices for laparoscopic surgery. The company was founded by the prestigious training institute WIMAT, a leading UK training facility for minimal access surgery. Its lead product is Innervision which offers a paradigm shift in the way in which surgical smoke is handled. Based upon proven technology used in commercially available non-medical products, the Innervision system has the following benefits: l Effective – rapidly clears smoke without requiring intervention by the surgeon l Silent, non-intrusive – does not require an air handling system or impact current surgical techniques and instrumentation l Convenient – no de-sufflation of the abdominal cavity l Highly efficient – no additional carbon dioxide use required l Non-drying – does not require carbon dioxide exchange Its follow-on products are a novel atraumatic manipulator and a variable length access port. Asalus intends to launch Innervision in 2012 and is seeking discussions with potential commercial and contract manufacturing partners.

Attending: David Muxworthy, Director of Alere Connected Health Ltd (formerly Home Telehealth Ltd)

Asalus

Attending: Dr Dominic Griffiths, Managing Director Dr Peter Grant, Chairman

WALES medica special

10

Awen Cymru Awen Consulting is a wholly owned subsidiary of the University of Wales (UW), providing project-managed services via a number of world class UW institutions and affiliates.

The Consulting group specialises in developing medical devices from prototype to market and draws on a wide pool of academic expertise including: UW Global Academy and Faculty, the Alliance, Swansea Metropolitan University and Trinity St. David.

Awen also works closely with the Institute of Life Science and the College of Engineering at Swansea University.

Expertise drawn upon includes medical and medical approvals processes, microbiology and genetics, engineering and physics, computer science, mathematics, product design and product approval.

Awen provides business, management and marketing support through the business schools. For manufacturing, Awen engages with UK manufactures where possible including plastic assembly, electronics, pharmaceutical and drug delivery.

Awen also has links to, and can initiate discussions with, Venture Capital and Health Care Funds.

Attending: Dr. Marcus Heuberger, MInstKT, Technology Transfer Manager Tel: +44 (0)7949906262 Tegid Roberts, Tel: +44 (0)7971907747, Email: t.roberts@awenwales.com

Boots Centre for Innovation Boots Centre for Innovation Institute of Life Science University of Swansea Swansea, Wales, UK SA2 8PP Tel: +44 (0) 1792 513 722 Email: info@bootsinnovation.co.uk www.bootsinnovation.com

The Boots Centre for Innovation seeks out innovative health and beauty products at any stage - from concept to shelf-ready - for Boots pharmacy-led stores worldwide. They are looking for consumer healthcare opportunities that can form part of the Boots Pharmaceuticals range as there are specific unmet innovation needs.

In return Boots offers entrepreneurs an array of support services that can help with the commercialisation of ideas. Embracing the principles of open innovation, the Centre compliments the established product development resources of Alliance Boots.

Objectives at Medica: l Seek out innovative consumer healthcare products and services which are suitable for Boots stores in the UK and throughout the global Boots distribution network. l Identify opportunities that could meet customers’ unmet healthcare needs.

80 Mochdre Enterprise Park Newtown Powys SY16 4LE Tel: +44 (0)1686 611333 Fax: +44 (0)1686 622946 Web: www.cellpath.co.uk

CellPath has established itself as a dynamic innovative company, and has anenviable reputation over 40 years for reliability and customer service in its role as market leading supplier of cellular pathology consumables. In addition to supplying a comprehensive range of pathology consumables, CellPath continues to be at the fore-front of the design and development of new products and services.

Objectives at Medica: Increase export market by meeting potential and existing suppliers, distributors and customers.

Attending: Gail Eastaugh, Business Development Manager

CellPath

Attending: Philip Webber, Managing Director Mark Wilson, Export Sales Manager

11 WA L E S PAV I L I O N D I R E CTO R Y

Chromogenex Units 1 & 2 Heol Rhosyn, Dafen Industrial Estate Llanelli Carmarthenshire SA14 8QG Tel: +44 (0)1554 755444 Fax: +44 (0)1554 755333 kwilliams@chromogenex.com www.chromogenex.com

Chromogenex is the UK’s leading developer and manufacturer of laser and intense pulsed light systems for the health, cosmetic and beauty market. Chromogenex have an extensive range of key products including: iLipo Ultra for fat reduction and body contouring, with vacuum massage which enhances lymphatic drainage including infra red skin tightening Fusion3DLift – a non-invasive face lift 3D rejuvenation Regenlite – a pulse dye laser for vascular, acne and skin pigmentation Chromogenex also sell peripheral consumables, service contracts and ancillary goods Phaser 808 - a laser diode for hair removal The company has established direct sales operations in the UK, USA, Spain and South African markets with further export sales via a comprehensive global network of distributors.

Objectives at Medica: To showcase the company’s latest product innovations.

Dermastar Ltd 23 Frogmore Street Abergavenny Monmouthshire NP7 5AH Tel: +44 (0)1873 851555 Fax: +44 (0)1873 851566 Email: info@acnestar.co.uk Web: www.acnestar.co.uk

Dermastar Ltd is a manufacturer of “home based” medical products based in the United Kingdom. They specialise in the development of innovative and cost effective solutions within the aesthetic and dermatological market. Their latest product, AcneStar® offers a breakthrough spot medication and treatment for acne. A revolutionary drug and chemical free acne treatment AcneStar® is a quality product of Dermastar Ltd that has gone through three years of design and product testing. The research and development of AcneStar® was partly funded by the Welsh Development Agency.

Acnestar is certified as meeting the requirement of EC Directive 93/42/EEC on Medical Device Annex IV for acne treatment and International Recognition.

Attending: Peter McGuinness, Managing Director Kevin Williams, Sales Director and Director

Dermastar

Direct Healthcare Services Direct Healthcare Services Ltd Units 8-10 Withey Court Industrial Estate, Western Industrial Estate, Caerphilly, Wales, UK CF83 1BQ Tel: +44 (0) 7837 242 731 (Neil) +44 (0) 7989 935 101 Tel Enquiry: +44(0)845 459 9831 Fax: +44 (0) 845 459 9832 Email: sales@direct-healthcare.org.uk

Attending: Jon Lewis/Neil Smith (Directors)

Multi award winning Direct Healthcare Services Ltd aspire to be one of the market leaders in the manufacturing process, supply, installation and service of pressure area care equipment.

With its primary manufacturing operation based in South Wales, Direct Healthcare’s management team have a wealth of experience in the provision of clinically proven, value for money solutions in this specialist sector.

Their combination of innovative technologies, designed in partnership with leading clinical healthcare establishments, meets the needs of most patient groups, including the increasingly elderly population.

Specialist teams are dedicated to serving customer needs, whilst continually striving to provide excellent customer support through a personalised one-on-one service.

Whether you need the provision of a managed pressure care contract, hospital installation or purchase of a single item, Direct Healthcare Services can meet your requirements.

WALES medica special

12

DTR Medical DTR Medical Ltd 17 Clarion Court Enterprise Park Swansea SA6 8RF Tel: +44 (0)1792 797910 Fax: +44 (0)1792 797955 Email: info@dtrmedical.com Web: www.dtrmedical.com

DTR Medical provides medical professionals with single-use sterile surgical instruments that deliver patient and clinical value combined with exceptional levels of service. The company has operated for six years and currently has more than 400 UK & international customers.

The DTR Medical range includes many new sterile single-use surgical instruments for specialities including ENT, neurosurgery, vascular and general surgery, and gynaecological procedures, with a new orthopaedic surgery selection being launched at Medica 2011.

In addition, the company supplies a range of products for sterile services including sterile pre-cut silicone tubing. DTR Medical continually expands its product range to meet new market demands.

Objectives at Medica: Recruit new international distributors to sell the new product range worldwide; meet existing distributors and suppliers; and look for new products.

EnviroPulp Ltd, Newbridge Road Industrial Estate, Pontllanfraith, Gwent, NP12 2AN, Wales Tel: +44 (0)1495 228838 Email: Fuad.Khan@enviropulp.co.uk; Harry.Kirk@enviropulp.co.uk Web: www.enviropulp.co.uk

Enviropulp is a leading producer of high specification pulp products for use in hospitals, clinics and care homes. Products exceed the requirements of all relevant international standards. Their approach is to manufacture and supply the very best quality pulp products available today.

The company has recently opened its new high technology manufacturing facility, with the most advanced thermo-forming pulp production equipment in the world.

EnviroPulp continue to develop innovative and unique products for use in the medical market.

Objectives at Medica: Showing the new Soap-Proof Washbowl and new line of high tolerance ThermoPulp Medical Trays.

They are looking to meet with potential professional distribution partners on a global basis who can see the potential of the products in their markets.

Attending: Andrew Davidson, Managing Director, Caroline Denise Mee, Business Manager

EnviroPulp

Attending: Fuad Khan, Commercial/Technical Director; Harry Kirk, Managing Director

GX Group The Mayfield Usk, Monmouthshire NP15 1SY Tel: +44 (0)1291 673437 Fax: +44 (0)1291 673438 Mobile: 07790315250 Email: claire.banks@gxgroup.com Web: www.gxgroup.com

Attending: Claire Banks, Business Development Manager, claire.banks@gxgroup.com Seb Wetherall, Industrial Designer, seb.wetherall@gxgroup.com

GX Group compromises of GX Design Engineers – Wales’ leading independent product design consultancy, GX Systems – a leading automation, control, I.T solutions and web based tracking developer and GX Environmental – UK market leaders in the design, installation and support services for tankered clean water and waste management logging.

GX Design Engineers offers clients within the medical industry a holistic approach to new product development and innovation. Their multidisciplinary design team is experienced in handling projects from conception through to production and implementation. Skills include industrial and mechanical design, electronic hardware and software design, ergonomics including user interfaces, optronics and mechatronics.

Benefits l Cost-effective approach to reduce risks and maximise your ROI l Confident and proven technical expertise l Successful products tailored to their market Objectives at Medica: To establish and present the recently formed GX Group and its component companies to the forefront of the European medical industry – focusing on medical manufacturers and service providers.

13 WA L E S PAV I L I O N D I R E CTO R Y

Huntleigh Tel: +44 (0)29 20485885 Email: sales@huntleigh-diagnostics.co.uk Web: www.huntleigh-diagnostics.com Hall 9; Stand A32

Huntleigh, a member of the Getinge group of companies, is a leading global provider of innovative and high quality medical equipment for healthcare professionals. The Diagnostic Products Division can proudly boast world leading brands such as Sonicaid, Dopplex and Smartsigns, covering healthcare requirements in obstetrics, vascular assessment and patient monitoring.

The ISO 13485 accredited site at Cardiff is the largest manufacturer of foetal monitors in the UK and its position has been strengthened with the introduction of portable foetal monitors; monitors with telemedicine capabilities and electronic viewing; and archiving systems. The Smartsigns brand of patient monitors compliment the obstetric and vascular business enabling Huntleigh to offer complete solutions to medical professionals world-wide. The site also offers expertise in electronic components and software that support product lines throughout the entire group.

The Magstim Company Ltd Spring Gardens Whitland Carmarthenshire SA34 0HR Tel: +44 (0)1994 240798 Fax: +44 (0)1994 240061 Email: john.scandone@magstim.com Web: www.magstim.com

Magstim maintains a strong commitment to R&D and product improvement. Collaborating with researchers in British and European major centres of expertise (as well as those in North America and Japan) ensures that Magstim remains informed about clinical and medical advances, enabling the company to develop products at the forefront of technology.

Products are sold directly to hospitals and clinics in the UK and Ireland and exports account for much of the Magstim business.

Principal markets are in Germany, France, Benelux, Japan, the Far East and the USA. Magstim enjoys a close and effective relationship with its specialist distributors and provides significant training and after sales service.

7 Schooner Way Atlantic Wharf Cardiff CF10 4DZ Tel: +44 (0)29 2047 3456 Email: debbie.laubach@mediwales. com Web: www.mediwales.com

MediWales has been active for over nineteen years and is the representative body for the life sciences sector in Wales. MediWales is in regular communication with over 1700 named contacts, and currently has over 130 subscribed members.

Supported by the Welsh Government, MediWales is owned by its members and led by directors drawn from senior industrialists and academics in Wales.

MediWales generates a unique environment for networking, collaboration and communication between industry, higher education and health service members. This is delivered through an active schedule of seminar events and publications, supported by the MediWales website and maintained via constant communication with members and stakeholders. From this pivotal role, MediWales is able to represent both its members and the wider sector to governmental and international partners.

Objectives at Medica: To support and promote members’ activity and to engage with the wider life science sector from Wales, the UK and beyond.  Â

Attending:

Greg Baily, Technical Director

Magstim

Attending: John Scandone, Director of Sales & Marketing Sam Jacobs, Customer Support Engineer

MediWales

Attending: Debbie Laubach, Project Manager

WALES medica special

14

PDR PDR (The National Centre for Product Design and Development Research) Western Avenue Cardiff, Wales CF5 2YB www.pdronline.co.uk Attending: Â Jarred Evans, Commercial Director Tel: +44 (0) 2920 41 6725 Email: jwevans@pdronline.co.uk Ashley Bryant, Senior Designer Tel: +44 (0) 2920 41 6725 Email: abryant@pdronline.co.uk

PDR is a world renowned design and innovation consultancy and research centre.

Over the last 17 years they have been using their unique and highly accessible approach to help large and small companies from around the world to discover, design and develop many successful medical devices and services encompassing classifications from simple disability devices and medial furniture through to complex diagnostic tools and drug delivery systems.

Device development at PDR is undertaken through a proven design methodology that employs the latest design and manufacturing analysis tools and technologies to produce robust, compliant and commercially successful solutions.

Pelican Feminine Healthcare Pelican Feminine Healthcare Ltd Cardiff Business Park Cardiff, Wales, CF14 5WF Tel: +44 (0)2920 747000 Fax: +44 (0)2920 747001 Web: www.pelicanfh.co.uk

Attending: James Eagle, Export Sales Manager Simone Steventon, Business Development Manager

Pelican manufactures a range of single-use instruments, specialising in Gynaecology products, which include the market leading PELIspec.

With state of the art manufacturing facilities and active research and development, the company has been instrumental in bringing many innovative products to the healthcare market. This, together with a positive input from specialist clinicians and other professional customers, ensures that Pelican remains at the forefront of providing clinically and cost effective products.

Pelican is passionate about delivering high quality medical products and world class levels of customer service. Their commitment to the Feminine Healthcare Market has led to the recent acquisition of Clinical Innovations Europe, who specialise in obstetrics and gynaecology instruments.

Objectives at Medica: They are looking to meet new European distributors (particularly from Romania, Hungary and Bulgaria) for their products as well as to meet inventors, suppliers or manufacturers of innovative obstetric and gynaecological products.

Polymer Health Technology Polymer Health Technology Ltd Festival Drive Ebbw Vale, Wales NP23 8XE Tel: +44 (0)1495 30228 Mob: +44 (0)7810 821382 (David) Mob: +44 (0)7966 841551 (Nick) Fax: +44 (0)1495 350189 Web: www.polyhealth.com

Attending: David Squirrell, Nick Woodman

Polymer Health Technology is Europe’s leading independent manufacturer of medical grade hydrophilic foam. Supplying exclusively to the medical industry and working to ISO 13485, Polymer Health Technology works in confidence with its partners to produce bespoke solutions to customer requirements. Hydrophilic foam is manufactured in a range of thicknesses and presented in bulk roll format or slit to customer desired widths. Foam can also be laminated to PU film or foam substrates. Formulations can be customised to incorporate antimicrobial or other beneficial additives to customer specific needs.

Having grown rapidly through 2011, Polymer Health Technology is currently expanding its manufacturing capabilities. With additional production facilities coming on stream in 2012, they will be furthering their ability to provide a high quality of service to customers and continue to develop innovative products.

15 WA L E S PAV I L I O N D I R E CTO R Y

Pulse Medical Technologies Pulse Medical Technologies Ltd Institute of Life Science Swansea University Singleton Park Swansea SA2 8PP Mob: +44 (0)792 1227776 Tel: +44(0)1792 606670 Email: iain.elder@pulsemedtech.com Web: www.pulsemedtech.com

Pulse Medical Technologies Ltd was incorporated to design and develop healthcare products, initially for the pain relief market.

The company has expanded its operations into other areas of healthcare, including wound care, using its core technology of Pulsed Electromagnetic Field Therapy (PEMF) as the base.

The company was awarded a major FP7 EC grant after submitting an idea for a new wound treatment, which incorporates the known healing properties of PEMF and the anti-bacterial properties of silver, within a unique dressing. A consortium was assembled to undertake the project and includes Swansea University and BSN Medical.

Pulse’s R&D base resides in the Institute of Life Sciences within Swansea University, giving it direct access to the extensive research facilities and world class experts in the medical and engineering fields, enabling the instigation of further research projects and expansion of the PainWave pain relief product portfolio.

Tonus Europe Limited Tredegar Business Park Tredegar Blaenau Gwent NP22 3EL, UK Tel: +44(0)79 888 111 75 Email: cmg@tonuseurope.com Web: www.tonuseurope.com

Tonus Europe Limited is creating new business opportunities in Western Europe, and wishes to distribute its products into new markets globally. Its UK office is part of the Tonus Healthcare Group whose headquarters is in the Latvian city of Liepaja on the Baltic coast.

Formed in 1995 with its new offices in the UK, Tonus are seeking distributors and partners for its existing and future product range.

Tonus manufactures a wide variety of elastic medical products, ranging from elastic bandages to complex corsetry. Tonus has established a market leading range of textile support, compression stockings and bandaging products sold through a well established sales channel in Eastern Europe.

Collaborating with universities and manufacturers here in the UK, Managing Director Chris Groves expects that his new base in Wales will lead to opportunities for new business, research and development projects as well as commercial ties between UK, the Baltics and beyond.

Wound Healing Research Unit (WHRU) School of Medicine Cardiff University Heath Park Cardiff CF14 4XN Tel: +44 (0)29 2045 3945 Email: reachmichaelclark@gmail.com

The Welsh Wound Network is a new collaborative organisation dedicated to improving the clinical care of people with wounds in Wales. The network brings together the wealth of academic, clinical and commercial expertise in wound healing in Wales to facilitate the development of new practices and innovations by undertaking high quality collaborative research, audit and other enquiries.

There are several well known and internationally respected research and clinical groups located in Wales including the Wound Healing Research Unit, the Surgical Materials Testing Laboratory, the AllWales Tissue Viability Nurse Forum among several others. In this new venture all of these well established groups have come together to explore areas where collaboration would lead to enhancements in research, practice and commercial innovation. This ongoing communication is supported by a roster of conferences and other networking events throughout the year.

Attending: Iain Elder

Tonus Europe

Attending: Chris Groves, Managing Director Dana Preiss, Sales Director Gatis Sturis, Export Specialist

Welsh Wound Network

WALES medica special

16

Alere Connected Health Due to Alere’s ‘first to market’ position in the UK in delivering such a service, Alere Connected Health Limited has won three consecutive National Awards in 2008-2011 for “Innovation and Partnering with the NHS”.

Alere Connected Health Ltd (formerly Home Telehealth Ltd) has over 12 years’ experience in delivering telehealth, telemedicine and technology-enabled care to the NHS and public and private healthcare organisations.

The company has delivered a full clinical managed service model for patients with long term conditions (LTC) over a four year period incorporating over 1,200 patients and 1,500 episodes of care. The telehealth managed service is a revenue not a capital model of care, enabling NHS Trusts and private healthcare providers to budget carefully and realise savings immediately. Old capital models of LTC management incorporating

expensive “front loaded” expenditure on technology are now consigned to history.

The chronic disease managed service incorporates all elements of a service delivery model including clinical and technical triage, installation, deinstallation, maintenance and support services, appropriate technology identification for the patient’s particular LTC, and purchase of all equipment together with customised data collation and feedback to the customer.

This final element is critical in supporting such a service model as it provides evidence to the commissioners of the benefits and outcomes achieved, whether that is a quick return on investment (ROI), reductions in unplanned emergency

admissions, the ability to discharge patients quicker from secondary care, or improvements in patients’ quality of care. Real data headline outcomes include 112% ROI, 50% reduction in unplanned emergency admissions across a number of high admission disease conditions, support to community clinicians in prioritising growing caseloads, and improvements in quality of care for patients.

Alere Connected Health Ltd Saint Line House Mount Stuart Square Cardiff CF10 5LR Tel: +44 (0)7876 712021 Email: david.muxworthy@alere.com Web: www.hometelehealthltd.co.uk

www.alere.co.uk

17

CellPath CellPath Ltd manufactures a wide range of products for the cellular pathology laboratory, also providing a unique archiving solution for pathological material.

With a large in-house plastic injection moulding facility, bulk chemical mixing and packaging and distribution operation, they provide a world-wide service, backed up by numerous dealers and resellers.

Their primary aim is to provide a first class service by delivering high quality histology and cytology consumables. This is achieved by continuous process improvement, internal audits and monitoring of all comments, suggestions and any complaints received from internal and external customers.

Currently accredited to ISO 9001:2008, CellPath plan to achieve ISO 13485:2003 accreditation by the end of 2011 and ISO 14001:2004 in 2012.

Many products offer cost-effective solutions to laboratories, with a comprehensive range of processing cassettes, slides, histological wax, filled specimen pots and stains and dyes, along with other laboratory consumables.

At Medica, CellPath will showcase a new innovative range of cassettes introduced to solve the problem of tracking large tissue specimens through the laboratory. In addition, Medica gives the company an opportunity to show how a Welsh

manufacturer has global ability in a growing market.

Their CellNass storage solution is proven, established and cost effective for the retention of pathological material in conditions required by local controlling bodies. The service was designed by experienced laboratory and business people for the specific needs of cellular pathology.

CellPath Ltd 80 Mochdre Enterprise Park Newtown Powys SY16 4LE Tel: +44 (0) 1686 611 333 Email: sales@cellpath.co.uk Web: www.cellpath.co.uk

WALES medica special

18

Chromogenex i-Lipo™ is the latest in laser lipolysis, offering a way to achieve inch loss and body contouring with no pain, no needles and no down time. i-Lipo™ is clinically proven, safe and painless targeted fat reduction, with immediate results, manufactured and maintained in the UK. The new i-Lipo Ultra Plus incorporates 36 laser diodes, vacuum massage with infra-red skin tightening to target more stubborn fatty deposits, enhance lymphatic drainage, improve blood circulation and promote skin renewal. i-Lipo Ultra Plus can deliver immediate results: the vacuum massage action of the Ultra enhances the removal of released fat cell contents. Its suction action optimises absorption of infrared laser in the dermis to promote collagen growth and enhance blood circulation in the area. The result is slimmer, tighter and smoother looking skin.

Chromogenex have recently received a clinical evaluation from Paris for i-Lipo.

The study was a prospective evaluation of 15 patients (12 women, 3 men) during a course of 8 i-Lipo treatment sessions over 4 weeks.

The included subjects were chosen as having a history of ‘resistant’ anatomical areas that had previously demonstrated nil improvement to regular gym exercise and diet control alone. 7 subjects had treatments on the thigh and 8 subjects had abdominal treatments. Direct circumference measurements of treated anatomy and echography measurements of fat layer thickness were recorded.

The second part of the study, histological and biological analysis was

Before

After

performed on human skin explants maintained in survival conditions, using light microscopy and assaying glycerol collagen synthesis levels after 5 i-Lipo simulated treatments on the tissue versus control (untreated) tissue.

Circumference measurements: An average of 4.16cms was reduced from (8) abdominal treatments.

An average of 1.5cms was lost from (8) thigh treatments Please contact Chromogenex directly for more information on the results of this study.

Chromogenex Ltd Units 1 & 2 Heol Rhosyn Dafen Industrial Estate Llanelli Carmarthenshire SA14 8QG Tel: +44 (0)1554 755444 Fax: +44 (0)1554 755333 kwilliams@chromogenex.com www.chromogenex.com

19

Direct Healthcare Services Direct Healthcare Services Ltd (DHS) was created less than three years ago in the medieval castle town of Caerphilly, South Wales.

Spearheaded by Managing Director Jon Lewis, DHS possesses a wealth of experience in the manufacturing processes and provision of clinically proven, pressure care solutions. The company has enjoyed tremendous growth since conception, winning three national awards in two years.

Having achieved 20% growth year on year within its primary UK market, DHS is looking to maximize export market opportunities.

Sales & Marketing Director Neil Smith comments, “Our next opportunity as a proud British manufacturer is to take our products, skills and experience, all of which require a high level of clinical understanding and attention to detail, to key overseas markets.”

DHS has recently conducted a pilot study within the Irish healthcare market. In keeping with its ‘Deliver the promise’ company slogan, the quality and clinical performance of its value for money products were fully welcomed – a great success

considering the competitive and complex product sector of pressure area care.

The company’s primary aim at Medica is to source and meet “strategic partners” willing to work alongside their vision for the future. They’re looking for distribution partners with

experienced teams to enable market penetration with the Dyna-Form(R), Dyna-Tek(R) and Dyna-Pad(R) brands throughout Europe and globally.

DHS’s combination of innovative technologies, designed in partnership with leading clinical healthcare establishments, meets the needs of targeted patient groups, including the increasingly elderly population.

Whether you need the provision of a managed pressure care contract, a hospital installation, want to purchase an item, or are interested in distribution opportunities in countries outside of the UK and Ireland, visit Jon or Neil on the Wales stand, or contact Direct Healthcare Services Ltd (see details below, quoting “Medica Enquiries” to the Customer Service team).

Direct Healthcare Services Ltd Units 8-10 Withey Court Industrial Estate Western Industrial Estate Caerphilly, Wales United Kingdom CF83 1BQ Mob: +44 (0) 7837 242 731 (Neil) Tel: +44(0)845 459 9831 Fax No: +44 (0) 845 459 9832 sales@direct-healthcare.org.uk

WALES medica special

20

DTR Medical DTR Medical Ltd – a leading sterile single-use surgical instrument manufacturer – is developing its business using advanced manufacturing techniques to enable high quality volume production.

Keen to innovate, reduce its carbon footprint, and encourage the use of single-use surgical instruments, DTR Medical is using computer aided design (CAD) and advanced moulding techniques to reproduce products previously sourced from Asia. For instance, the increasingly popular Frazier Suction Handle is now produced locally, enabling DTR Medical to meet the high demand for the product.

Integral to the company is the adherence to international quality standards. By using CAD and automated procedures to produce the Frazier suction handles, the margin of error has been significantly reduced, providing standardized high quality product every time.

Linking the ability to innovate and use the latest lean manufacturing techniques, the company has worked with clinicians to develop their Sterile Single-use Rotating Cervical Biopsy Punch, to remove the risks of cross contamination for patients undergoing cervical cancer biopsies.

With approximately 260,000 cervical biopsies conducted in the UK per annum, DTR Medical’s product has the opportunity to revolutionise this procedure, as it prevents crosscontamination, provides first time sharpness with a precise cut, and fits within healthcare providers’ budgets.

Sterile, Single-use Rotating Cervical Biopsy Punch

Sterile, Single-use Frazier Suction Handles

The nylon-based trigger handle and the metal jaw were developed using the best materials and expertise available, utilising the advice of surgeons to create a truly fit-for-purpose product.

The shaft and inner rod - made from stainless steel - actuate the jaw, ensuring no movement or flex occurs, enabling the surgeon to attain a sharp and clean cut.

The product will be launched at a cost effective and affordable price, considerably less than what healthcare providers could pay for a Far East manufactured instrument.

DTR Medical Ltd 17 Clarion Court Clarion Close Enterprise Park Swansea SA6 8RF UK Tel: +44 (0) 1792 797 910 Fax: +44 (0) 1792 797 955 E-mail: info@dtrmedical.com Web: www.dtrmedical.com

21

GX Group GX Design Engineers is one of the UK’s leading technology and innovation companies. They offer clients, and specifically those in the medical sector, a multidisciplinary and holistic approach to new product design and development.

GX has the ability to turn ideas into viable commercial products that meet the demanding technical requirements of your market.

Comprising a friendly and flexible team of professionals, GX take professional pride in helping clients with multifaceted challenges.

Clients’ needs are met through engineering excellence and skilful differentiation to deliver products that maintain or grow market share and provide competitive edge.

The in-house team’s skill set includes electronic hardware and software design, industrial and mechanical engineering, with specialists in areas such as optronics and microfluidics.

Combing these capabilities with creativity, experience and absolute problem solving intelligence, GX deliver innovative and commercial solutions that function as required.

Bayer - Clinitek Status - Urine & immuno diagnostics

Products are aesthetically attractive, ergonomically sound, and can be brought to market quickly. Produced within your target cost, GX can help clients achieve the required return on investment.

GX Group The Mayfield USK Monmouthshire UK NP15 1SY Tel: +44 (0)1291 673437 Web: www.gxgroup.com Isurgicals - Laparoscopic trainer

WALES medica special

22

Pulse Medical Technologies Pulse Medical Technologies Ltd (Pulse) was incorporated to design and develop health care products, initially for the pain relief market. The company has grown and expanded its operations into other areas of healthcare, including wound care, using its core technology of Pulsed Electromagnetic Field Therapy (PEMF) as the base.

PEMF has been used for decades and is FDA approved for various conditions including healing non-union bone fractures, wounds and pain relief. The technology doesn’t have any magnets and has a different mechanism to other treatments e.g. TENS.

Products PainWave X4000 is the company’s pain relief product and has been used successfully by thousands of people covering a wide range of conditions.

Further products are in development.

FP7 Project The company was awarded a major FP7 EC grant after submitting an idea for a new wound treatment, which incorporates the known healing properties of PEMF and the antibacterial properties of silver, within a unique dressing. A consortium was assembled to undertake the project and includes Swansea University and BSN Medical.

Collaboration with the Institute of Life Science and Swansea University Pulse’s R&D base resides in the Institute of Life Science within Swansea University, Wales, giving it direct access to the extensive research facilities and world class experts in the medical and engineering fields. In addition to the full time post doctorate team, backed by specialist professors working on the FP7 project, the company has appointed a post doctorate to undertake specific research to expand its offering into underserved commercial markets that require innovative solutions.

Medica The company views Medica as an important event for publicising its products and research projects, and for expanding collaborations with research partners, potential suppliers, distributors and customers. In addition, it provides an insight into trends and innovations and provides a valuable resource for competitor analysis.

Pulse Medical Technologies Ltd Swansea University Singleton Park Swansea SA2 8PP Tel: +44 (0)1792 606670 Email: francis.cooper@ pulsemedtech.com

Wales 10th Year at Medica

Life Sciences is a priority sector for the Welsh economy.

330 Companies 15,000 Employees Focus on Research & Development Come and visit us. Hall 16, Stand no F30.

Visit business.wales.gov.uk, call the Welsh Government information helpline for business on 03000 6 03000 or email businesssupport@wales.gsi.gov.uk Welsh Government Medica Ad A5.indd 1

26/10/2011 11:30

Exploiting your ideas Affordably!

• Patents • Designs

• Trade Marks • Domain Names

Offices in Cardiff and Cheltenham Tel: +44 (0) 2920 786535 Email: email@wynne-jones.com Web: www.wynne-jones.com

Protecting your ideas Inventively!